FDA has launched a new “plausible mechanism pathway” to help expedite approvals of personalized treatments for rare diseases, in today’s bite-sized hospital and health industry news from the District of Columbia, Maryland, and Washington. District of Columbia: Ann Mond Johnson, CEO of the American Telemedicine Association (ATA), will retire from her position, effective Dec. 10. […]
